Trial Profile
The Role of Tetracyclines in the Personalised Management of MMP-9 and Cardiovascular Function in Type 2 Diabetes
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2017
Price :
$35
*
At a glance
- Drugs Minocycline (Primary)
- Indications Cardiovascular disorders
- Focus Pharmacodynamics
- Sponsors Solvotrin Innovations
- 04 Jul 2017 This trial has been completed in Ireland on (2017-04-10), according to European Clinical Trials Database.
- 21 Oct 2015 New trial record